Pain Therapy R&D Innovation, Investment Declining, BIO Reports

 
• By Joseph Haas

Since 2017, BIO has noted a decline in pain therapy pipeline candidates, with a high attrition rate in the space and meager investment. The situation is grim for addiction-treatment therapy too, a new report points out.

Pain medication
Innovation in pain therapy is not keeping up with need, BIO finds • Source: Shutterstock

More from R&D

More from Scrip